Trilantic Capital Partners is selling its stake in Fortitech as part of the company's announced sale to Royal DSM for a total enterprise value of $634 million. Fortitech develops custom food ingredient premixes and blends for the food and beverage, infant nutrition and dietary supplements industries. Trilantic invested in the company in 2010 to support its global expansion.
